Start for free
Start for free
GS

Grey Sky Venture Partners

North America, Washington, United States, Bellevue

Description

Grey Sky Venture Partners is a new early-stage investment firm that invests in the areas of healthcare sectors.

Investor Profile

Grey Sky Venture Partners has made 9 investments, with 0 in the past 12 months and 33% as lead.

Stage Focus

  • Series A (56%)
  • Seed (22%)
  • Series C (11%)
  • Series B (11%)

Country Focus

  • United States (78%)
  • Canada (22%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Product Research
  • Artificial Intelligence (Ai)
  • Health Diagnostics
  • Medical Device
  • Therapeutics
  • Market Research
  • Augmented Reality
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Grey Sky Venture Partners frequently co-invest with?

Fresenius Medical Care
Fresenius Medical Care
Europe, Hessen, Germany, Bad Homburg
Co-Investments: 2
FundRx
FundRx
North America, New York, United States, New York
Co-Investments: 1
MBX Capital
MBX Capital
North America, New York, United States, New York
Co-Investments: 1
Hikma Ventures
Hikma Ventures
Europe, England, United Kingdom, London
Co-Investments: 2
Fusion Fund
Fusion Fund
North America, California, United States, Palo Alto
Co-Investments: 1
TEDCO
TEDCO
North America, Maryland, United States, Columbia
Co-Investments: 1
Mitsubishi UFJ Capital
Mitsubishi UFJ Capital
Asia, Tokyo, Japan, Tokyo
Co-Investments: 2
Dingman Center for Entrepreneurship
Dingman Center for Entrepreneurship
North America, Maryland, United States, College Park
Co-Investments: 1
M Ventures
M Ventures
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 2
Abell Foundation
Abell Foundation
North America, Maryland, United States, Baltimore
Co-Investments: 1

Which angels does Grey Sky Venture Partners often collaborate with?

LB
Luigi Bajetti
North America, California, United States, Menlo Park
Shared Deals: 1

What are some of recent deals done by Grey Sky Venture Partners?

Inflammatix

Burlingame, California, United States

Inflammatix develops novel molecular diagnostics for acute infections and sepsis that work by reading the immune system.

Big DataBioinformaticsBiotechnologyHealth CareHealth Diagnostics
Series CJan 10, 2020
Amount Raised: $32,000,000
Winterlight Labs

Toronto, Ontario, Canada

Winterlight builds technology that can quickly and accurately detect signs of cognitive impairment from a sample of speech.

Artificial Intelligence (AI)Information TechnologyMachine LearningNeuroscienceProduct ResearchSpeech Recognition
Series ANov 18, 2019
Amount Raised: $4,230,000
AmacaThera

Toronto, Ontario, Canada

AmacaThera's injectable hydrogel platform provides localized, sustained drug delivery to improve patient outcomes.

BiopharmaBiotechnologyTherapeutics
SeedOct 3, 2019
Amount Raised: $2,699,045
Altoida

Washington, District of Columbia, United States

Altoida is creating a new gold standard in brain health with Precision Neurology.

Artificial Intelligence (AI)Augmented RealityHealth CareHealth DiagnosticsMedicalMedical DevicemHealthSoftware
Series AMay 23, 2019
Amount Raised: $6,300,000
Modulim

Irvine, California, United States

Light based technology sees beyond the visual, bringing exciting new insights to research, aesthetics and medicine.

Market ResearchProduct Research
Series BJan 23, 2019
Amount Raised: $7,000,000
HepaTx

Palo Alto, California, United States

Hepatx is developing regenerative medicine solutions.

BiotechnologyMedicalTherapeutics
SeedAug 20, 2018
Amount Raised: $2,100,000
Biolinq

San Diego, California, United States

Biolinq develops a wearable biosensor platform that is capable of measuring blood level information.

BiotechnologyHealth CareMedical DeviceWearables
Series ANov 27, 2017
Amount Raised: $10,000,000
Modulim

Irvine, California, United States

Light based technology sees beyond the visual, bringing exciting new insights to research, aesthetics and medicine.

Market ResearchProduct Research
Series ANov 16, 2017
Amount Raised: $2,900,000
Sonavex

Baltimore, Maryland, United States

Sonavex is a developer of an imaging technology designed to visualize and quantify critical data to detect anastomotic blood clots.

BiotechnologyHealth CareMedical
Series AApr 24, 2017
Amount Raised: $4,500,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator